Coronary interventions - Mini focus on drug-eluting stents and drug-coated balloons

Coronary vasomotion after treatment with drug-coated balloons or drug-eluting stents: a prospective, open-label, single-centre randomised trial

EuroIntervention 2022;18:e140-e148. DOI: 10.4244/EIJ-D-21-00636

Tsutomu Kawai
Tsutomu Kawai1, MD; Tetsuya Watanabe1, MD, PhD; Takahisa Yamada1, MD, PhD; Takashi Morita1, MD, PhD; Yoshio Furukawa1, MD, PhD; Shunsuke Tamaki1, MD, PhD; Masato Kawasaki1, MD; Atsushi Kikuchi1, MD; Masahiro Seo1, MD; Jun Nakamura1, MD; Kentaro Tachibana2, MAS; Hirota Kida2, MAS; Yohei Sotomi3, MD, PhD; Yasushi Sakata3, MD, PhD; Masatake Fukunami1, MD, PhD
1. Division of Cardiology, Osaka General Medical Center, Osaka, Japan; 2. Clinical Engineering Department, Osaka General Medical Center, Osaka, Japan; 3. Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan

Background: Although recent studies have reported that drug-coated balloons (DCB) are non-inferior to drug-eluting stents (DES) for the treatment of native coronary arteries in a specific population, there is no available information concerning vasomotion after treatment with DCB.

Aims: The aim of this study was to prospectively compare coronary vasomotion in patients with small coronary artery disease treated with DCB versus DES.

Methods: Forty-two native lesions (2.0-3.0 mm) treated in our institution were randomly assigned to the DCB arm (n=19) or the bioabsorbable polymer everolimus-eluting stents arm (n=23) after successful predilation. At eight months after treatment, endothelium-dependent and -independent vasomotion was evaluated with intracoronary infusions in incremental doses of acetylcholine (right coronary artery: low dose 5 μg, high dose 50 μg; left coronary artery: low dose 10 μg, high dose 100 μg) and nitroglycerine (200 μg). The mean lumen diameter of the distal segment, beginning 5 mm and ending 15 mm distal to the edge of the treated segment, was quantitatively measured by angiography.

Results: The luminal dimension in the treated segment did not differ between groups at the follow-up angiography. The vasoconstriction after acetylcholine infusion was less pronounced in the DCB arm than in the DES arm (low-dose: 6±13% vs –3±18%, p=0.060; high-dose: –4±17% vs –21±29%, p=0.035). The response to nitroglycerine did not differ between groups (17±13% vs 17±22%, p=0.929).

Conclusions: Vasoconstriction after acetylcholine infusion in the peri-treated region was less pronounced in the DCB arm than in the DES arm, suggesting that endothelial function in treated coronary vessels could be better preserved by DCB than by new-generation DES.

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

drug-coated balloondrug-eluting stentqcastable angina
Read next article
Clinical outcomes of suboptimal stent deployment as assessed by optical coherence tomography: long-term results of the CLI-OPCI registry

Latest news